Prevent summer flu with DCL Panalgan Flu

Prevent summer flu with DCL’s Panalgan® Flu
30 May, 2019
Vikoda sponsors for the Closing Ceremony – Awarding at Nguyen Van Troi High School, Khanh Hoa province
2 June, 2019

Summer sweltering weather, with the use of air conditioning, has made a big difference between indoor and outdoor temperature, which is one of the causes of cough or flu. Panalgan flu of DCL will help to recover quickly from the flu.

Flu is a very common disease, which makes people feel tired, uncomfortable and people often tend to buy medicine for treatment. Symptoms of the common cold usually appear about 1-3 days after being exposed to a flu virus. Signs and symptoms include: a runny or stuffy nose, itching or sore throat, coughing, congestion in the eyes, watery eyes, body aches or mild headaches, sneezing, fever and fatigue.

Panalgan flu of DCL works to treat symptoms of flu like cough, fever, headache, muscle aches, osteoarthritis, nasal congestion, runny nose, tears, eye irritation. In addition, Panalgan flu can also be used for sinusitis, seasonal allergic runny nose, itchiness, seasonal or year-round allergic rhinitis.

Being considered one of the key products in DCL’s pharmaceutical segment, Panalgan flu has been invested to change the model with a more modern and closer image to users. And since the new label was changed, Panalgan flu has not only helped strengthen the DCL brand in the Vietnamese pharmaceutical market but also contributed to the company’s performance.

With the mission of connecting and improving the life of the community through optimal health solutions, DCL’s leaders and staffs have been making continuous efforts to bring DCL into a Vietnamese pharmaceutical company which is appreciated by patients, staff and partners because of innovative products and services that are accessible and best cared. And since becoming a member of the FIT Group, with the strategic orientation from the parent company, DCL has been invested in large projects and expanded its operations effectively, restructuring process and since the investment in DCL is gradually being completed, which is expected to bring great results in the future, helping the company step by step to become one of the leading pharmaceutical companies in Vietnam.